Table 2.
DN vs. NDN | SIH vs. NDN | DH vs. NDN | SIH vs. DH | |||||
---|---|---|---|---|---|---|---|---|
Variables | OR (95% CI) | p | OR (95% CI) | p | OR (95% CI) | p | OR (95% CI) | p |
Sex | <0.001 | 0.741 | 0.013 | 0.104 | ||||
Male | 0.61 (0.48–0.78) | 0.95 (0.71–1.27) | 0.69 (0.52–0.93) | 1.38 (0.94–2.03) | ||||
Female | 1.65 (1.29–2.11) | 1.05 (0.79–1.40) | 1.45 (1.08–1.94) | 0.73 (0.49–1.07) | ||||
Age | - | <0.001 | - | 0.544 | - | <0.001 | - | <0.001 |
Comorbidity | ||||||||
HTN | 7.08 (5.43–9.23) | <0.001 | 0.96 (0.69–1.34) | 0.826 | 5.40 (3.99–7.30) | <0.001 | 0.18 (0.12–0.27) | <0.001 |
CAD | 2.90 (1.92–4.38) | <0.001 | 0.88 (0.44–1.78) | 0.719 | 3.46 (2.20–5.43) | <0.001 | 0.25 (0.12–0.55) | <0.001 |
CHF | 5.08 (1.83–14.12) | 0.003 | 2.93 (0.77–11.14) | 0.122 | 6.51 (2.24–18.96) | 0.002 | 0.45 (0.11–1.83) | 0.321 |
CVA | 4.59 (3.04–6.94) | <0.001 | 0.38 (0.12–1.22) | 0.091 | 3.02 (1.78–5.12) | <0.001 | 0.13 (0.04–0.43) | <0.001 |
ESRD | - | 1.000 | - | 1.000 | - | 1.000 | - | - |
ISS, median (IQR) | - | <0.001 | - | <0.001 | - | 0.194 | - | <0.001 |
Mortality, n (%) | 0.95 (0.62–1.46) | 0.822 | 5.12 (3.72–7.05) | <0.001 | 2.45 (1.67–3.57) | <0.001 | 2.09 (1.35–3.25) | 0.001 |
ICU LOS (days) | - | 0.001 | - | <0.001 | - | <0.001 | - | 0.986 |
Pneumonia | 2.27 (1.45–3.58) | <0.001 | 1.27 (0.68–2.38) | 0.450 | 2.43 (1.45–4.07) | 0.001 | 0.52 (0.25–1.10) | 0.084 |
ARF | 2.44 (1.06–5.62) | 0.049 | 1.64 (0.55–4.88) | 0.324 | 1.34 (0.39–4.58) | 0.500 | 1.23 (0.27–5.54) | 1.000 |
HTN = hypertension; CAD = coronary artery disease; CHF = congestive heart failure; CVA = cerebral vascular accident; ESRD = end-stage renal disease; ISS = injury severity score; IQR = interquartile range; ICU = intensive care unit; LOS = length of stay; ARF = acute renal failure; NDN = nondiabetic normoglycemia; DN = diabetic normoglycemia; SIH = stress-induced hyperglycemia; DH = diabetic hyperglycemia; CI = confidence interval; OR = odds ratio.